Table 2.
VOR(0.1 Hz) | VOR(1 Hz) | |||
---|---|---|---|---|
Drug | ΔGain† | ΔPhase lead ‡ (deg) | ΔGain† | ΔPhase lead ‡ (deg) |
l-NAME | 0.06 | 2.7 | −0.03 | −3.8 |
0.08* | 2.7 | 0.03 | 1.6 | |
0.03 | 0.6 | 0.06 | −1.0 | |
−0.01 | 3.1 | 0.03 | −0.9 | |
0.03 | 0.2 | 0.01 | 1.4 | |
Bicuculline | −0.02 | 1.4 | −0.03 | 3.4 |
0.01 | 11.2* | 0.00 | −0.1 | |
0.08* | 11.0* | 0.09 | 2.7 | |
Strychnine | −0.10* | 7.5* | −0.08 | 2.4 |
−0.07 | −0.6 | 0.10 | −1.1 | |
0.10* | 1.4 | 0.0 | −0.4 |
Values represents changes in VOR gain afte drug injection. Absolute gain values in control conditions were 0.82 ± 0.04 for 0.1 Hz and 0.96 ± 0.05 for 1 Hz, n = 6.
Values represent changes in VOR phase lead after drug injection. Absolute phase lead values in control conditions were 9.7 ± 1.4 for 0.1 Hz and 6.0 ± 1.1 for 1 Hz, n = 6.
P < 0.05 when gain ad phase leads before and after injection were compared.